Clinical Trial Update: Study of Methylnaltrexone (MNTX) for the Relief of Constipation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for methylnaltrexone (MNTX) assessing relief of opioid-induced constipation in advance illness patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation in Advance Illness Patients

Drugs mentioned

• Methylnaltrexone (methylnaltrexone)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Advance Illness Patients With OIC | Phase 3 | Status: COMPLETED